Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × HER2-positive Metastatic Breast Cancer × Drug Therapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 22 Colorectal Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Neoplasms 9 Lung Neoplasms 9 Stomach Neoplasms 8 Neoplasm Metastasis 5 Colonic Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Triple Negative Breast Neoplasms 3 Small Cell Lung Carcinoma 3 Pancreatic Neoplasms 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Osteosarcoma 2 Neoplasms, Second Primary 2 Multiple Myeloma 2 Melanoma 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Head and Neck Neoplasms 2 Fatigue 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Thyroid Diseases 1

Interventions

palbociclib 1 Fulvestrant 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05188495 2022-01-12

HELP

Peking University Cancer Hospital & Institute

HER2-positive Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡